NeurAxis
NRXS | AMEX
$4.80
-$0.62 (-11.44%)
At close: Nov 16, 2026, 4:00 PM ET
$4.73
-$0.07 (-1.46%)
After-hours:
Nov 16, 2026, 5:46 PM ET
-11.44%
(1D)No price chart data available for 1D timeframe.
Rating
54.2
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #201/1021 (Top 20%)
Key Statistics
Market Data
Market Cap $68.13M
1D Range
4.71 5.30
52W Range
2.31 8.81
Valuation (TTM)
PE -4.57
PB 18.81
EV/EBITDA -5.36
Valuation (NTM)
Forward PE N/A
Forward PEG 0.27
Price Target $8.00
Cash Flow
FCF Yield -9.5%
SBC Adj. FCF Yield -17.1%
SBC Impact -80.1%
Margins
Gross Margin 86.2%
Operating Margin -186.2%
FCF Margin -99.1%
Growth (CAGR)
Revenue 3Y | 5Y 37.0% |
13.1%
Dil EPS 3Y | 5Y 29.9% |
-9.3%
FCF 3Y | 5Y 4.1% |
-25.5%
Returns
ROA -184.7%
ROE -252.1%
ROIC -306.0%
Financial Health
Net Cash
$4.27M
Current Ratio 2.10
Interest Coverage -287.04
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to al...
Sector Healthcare
Industry Biotechnology
Employees 24
IPO Date Aug 9, 2023
Website neuraxis.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 9, 2026
EPS
-$0.52
Miss -147.62%
YoY:
-116.67% REV
$2.03M
Miss -3.43%
YoY:
+149.92%Next Earnings
Mar 18, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$8.00
Upside
+66.67%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove NRXS